乳腺癌

HER2 阳性乳腺癌辅助曲妥珠单抗治疗预后的影响因素

Influencing Factors of Prognosis in Adjuvant Trastuzumab Therapy for HER2-Positive Breast Cancer.

1 厘米或以下的 I 期乳腺癌的辅助治疗

Adjuvant treatments for stage I breast cancers of one centimeter or less.

三阴性乳腺癌中化疗和化疗免疫治疗疗效差异的外周免疫动态变化

Differential peripheral immune dynamics underlie therapeutic response to chemotherapy and chemoimmunotherapy in triple-negative breast cancer.

髓系细胞触发受体（TREM-1）和 TREM-2 作为三阴性乳腺癌新辅助治疗病理完全缓解的预测因子

Triggering receptors expressed on myeloid cells (TREM-1) and TREM-2 as predictors of pathological complete response to neoadjuvant therapy in triple-n

基质 TREM-1 和 TREM-2 与 pCR 的相反关联表明，TIL 介导的肿瘤微环境可能在塑造 TNBC 治疗敏感性方面发挥重要作用。TREM-1 高表达与炎症性、治疗应答表型相关，而 TREM-2 高表达则反映免疫抑制性、耐药状态。对二者进行联合评估可能为预测 TNBC 治疗应答以及开发新型免疫调节策略提供具有临床意义的见解。

乳腺癌中巨噬细胞的代谢重编程：机制与治疗意义

Metabolic Reprogramming Of Macrophages In Breast Cancer: Mechanisms And Therapeutic Implications.

仿生血小板膜包裹的纳米胶束通过协同缓解缺氧和激活免疫以增强 TNBC 的免疫治疗

Biomimetic platelet membrane-camouflaged nanomicelles for synergistic hypoxia alleviation and immune activation to potentiate immunotherapy in TNBC.

基于 DNA 超分子水凝胶的保护性 NK 细胞储库用于增强三阴性乳腺癌治疗

Protective NK Cell Reservoir Based on DNA Supramolecular Hydrogel for Enhanced Triple-Negative Breast Cancer Therapy.

声遗传学纳米药物激活 cGAS-STING 通路用于三阴性乳腺癌的免疫治疗

Sonogenetics Nanomedicine Activates the cGAS-STING Pathway for Immunotherapy of Triple-Negative Breast Cancer.

结合胶原蛋白的 IL-15 免疫细胞因子武装溶瘤腺病毒建立自我强化的免疫刺激环境以增强抗肿瘤免疫

Collagen-Binding IL-15 Immunocytokine Armed Oncolytic Adenovirus Establishes a Self-Reinforcing Immunostimulatory Milieu to Potentiate Antitumor Immun

细菌 RNA 下调肿瘤细胞系 MHC-I 并促进 NK 反应、延缓肿瘤生长

Bacterial RNA downregulates MHC-I in tumor cell lines, promoting NK response and delaying tumor growth.